The Pennant Group (PNTG) Q3 2024 earnings summary

Executive summary

• Q3 2024 revenue reached $180.7 million, up 28.9% year-over-year, driven by strong growth in home health, hospice, and senior living segments.

• Net income for Q3 2024 was $6.2 million, a 41.6% increase from the prior year; GAAP diluted EPS was $0.20, and adjusted EPS was $0.26.

• Adjusted EBITDA for Q3 2024 was $15.7 million, up 39.2% year-over-year; adjusted net income was $8.2 million, up 36.8%.

• Growth was supported by acquisitions of multiple home health, hospice agencies, and senior living communities during the year.

• Recent equity offering and expanded revolving credit facility post-quarter enhanced financial flexibility and resulted in zero debt.

Financial highlights

• Q3 2024 consolidated revenue: $180.7 million (+28.9% YoY); adjusted EBITDA: $15.7 million (+39.2% YoY); adjusted EBITDAR: $26.0 million (+25.9% YoY).

• Adjusted EPS for Q3 2024 was $0.26; GAAP diluted EPS was $0.20.

• Net income for Q3 2024 was $6.2 million; adjusted net income was $8.2 million.

• Cash at quarter end: $4.5 million; net cash from operations (nine months): $18.7 million.

• Gross margin for Q3 2024 was 20.0%; operating margin was 6.0%.

Outlook and guidance

• 2024 annual adjusted revenue guidance raised to $665.3–$706.5 million; adjusted EBITDA guidance increased to $51.9–$55.2 million; adjusted EPS guidance now $0.90–$0.96.

• Guidance reflects strong operations, hospice rate adjustments, lower interest expense, and JV contributions.

• Guidance excludes unannounced acquisitions, announced purchase of Signature's Oregon assets, start-ups, share-based compensation, and one-time items.

• Management expects margin fluctuation due to acquisitions and integration of new operations.

• Anticipates ongoing competitive and inflationary pressures in senior living, impacting occupancy and rate growth.